Skip to main content
Clinical Trials/JPRN-UMIN000027114
JPRN-UMIN000027114
Not yet recruiting
未知

Promotion of exploratory research into healthy and ocular diseases biomarkers discovery in Taiwa medical examination - Healthy and ocular diseases biomarkers discovery

Tohoku University Graduate School of Medicine. Department of Ophthalmology0 sites600 target enrollmentApril 24, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Subjects received Taiwa medical examination.
Sponsor
Tohoku University Graduate School of Medicine. Department of Ophthalmology
Enrollment
600
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 24, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Tohoku University Graduate School of Medicine. Department of Ophthalmology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Subjects who do not consent in this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Withdrawn
Not Applicable
A study in healthy volunteers to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of BN201, an investigational compound for the treatment of acute optic neuritis.inflammation of the optic nerve.10030061
NL-OMON42731Bionure Pharma S.L. Barcelona32
Recruiting
Phase 1
Systematic biology research for healthy people of different ages and gendersAging disease
ITMCTR1900002711Tianjin University of Traditional Chinese Medicine
Active, not recruiting
Not Applicable
Treatment of patients, who have Mucopolysaccharidosis Type I, receiving pentosan polysulfate subcutaneous injections weeklyMucopolysaccharidosis type I (alpha-L-Iduronidase deficiency)MedDRA version: 17.0Level: LLTClassification code 10056888Term: Mucopolysaccharidosis ISSystem Organ Class: 100000004850MedDRA version: 17.0Level: LLTClassification code 10056887Term: Mucopolysaccharidosis IH/SSystem Organ Class: 100000004850MedDRA version: 17.0Level: LLTClassification code 10028094Term: Mucopolysaccharidosis IHSystem Organ Class: 100000004850Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2014-000350-11-DEMultiplex Pharma Holdings LLC6
Active, not recruiting
Phase 1
Detect GHBIntoxicationTherapeutic area: Diseases [C] - Nervous System Diseases [C10]
CTIS2022-501329-18-00Aarhus University30
Completed
Not Applicable
A first-in-human explorative pilot study in healthy volunteers measuring eye parameters with a new mobile phone application for future monitoring of patients in treatment of substance use disorder.substance use disorder (SUD)addiction
NL-OMON53553Kontigo Care AB48